<DOC>
	<DOCNO>NCT00865917</DOCNO>
	<brief_summary>The study compare three treatment modality human model Postural orthostatic tachycardia syndrome ( POTS ) : beta-blockers , I ( f ) -blockers , placebo .</brief_summary>
	<brief_title>Cardiovascular Effects Selective I ( f ) -Channel Blockade</brief_title>
	<detailed_description>Elevated heart rate may lead cardiac disease long-term . Therefore , drug lower heart rate useful . Beta-blockers establish treatment modality . They low heart rate also contractility , might undesirable certain tachycardic disorder . Postural orthostatic tachycardia syndrome ( POTS ) patient complain dizziness , weakness , headache , lightheadedness , fatigue , nausea , presyncope . In patient elevated heart rate even supine rest . In POTS patient preferable low heart rate without reduce cardiac contractility achieve use so-called I ( f ) -blockers . Thus , might superior beta-blockers POTS . In study , artificially generate POTS healthy male subject 48 hour . We want compare cardiovascular effect orthostatic tolerance follow treatment : beta-blocker , I ( f ) -blocker , placebo . Moreover , quantify change cardiovascular autonomic regulation bring I ( f ) -blockade versus placebo .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>healthy male age 1840 year BMI : 1830 kg/m² arterial blood pressure &lt; =160/100 mm Hg cooperativity voluntariness condition treatment might ineffective insecure comedication within last 4 week participation another clinical trial within last 4 week unability understand study 's aim drug alcohol abuse secondary hypertension creatinine &gt; 130 μM ( 1.47 mg/dl ) GOT/GPT &gt; 2 time normal GGT &gt; 3 time normal contraindication reboxetine , betablocker , ivabradine asthma , psoriasis diabetes heart failure ( NYHA III IV ) coronary artery disease peripheral occlusive disease cerebrovascular disease ventricular extrasystole ( Lown IIIV ) atrial fibrillation rest heart rate &lt; 60/min neurologic/psychiatric disorder pulmonary hypertension dysthyroid metabolism</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>POTS</keyword>
</DOC>